Biotech Profile
Alligator Bioscience – Engineering CD40 Agonism from Academic Roots to Phase 3 Readiness
Swedish biotech Alligator Bioscience outlines how strategic antibody engineering and focused execution positioned mitazalimab for pivotal trials in metastatic pancreatic cancer, transforming from university research into a Phase 3-ready immunotherapy program. Founded in 2001 and headquartered in Lund, Sweden, Alligator
4 August 2025